Matthew B. Klein - Jan 7, 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Chief Operating Officer
Signature
/s/ Avraham S. Adler, attorney-in-fact
Stock symbol
PTCT
Transactions as of
Jan 7, 2022
Transactions value $
-$29,857
Form type
4
Date filed
1/11/2022, 03:18 PM
Previous filing
Jun 28, 2021
Next filing
Apr 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale -$29.9K -775 -4.5% $38.53 16.5K Jan 7, 2022 Direct F1, F2
transaction PTCT Common Stock Award $0 +21K +127.57% $0.00 37.5K Jan 7, 2022 Direct F3
transaction PTCT Common Stock Award $0 +20K +53.39% $0.00 57.5K Jan 7, 2022 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTCT Stock Option (Right to Buy) Award $0 +52.5K $0.00 52.5K Jan 7, 2022 Common Stock 52.5K $38.10 Direct F5
transaction PTCT Stock Option (Right to Buy) Award $0 +50K $0.00 50K Jan 7, 2022 Common Stock 50K $38.10 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 2,250 RSUs from a January 6, 2021 grant of 9,000 RSUs.
F2 Includes 203 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 224 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021.
F3 Restricted stock units granted on January 7, 2022 that vest in four equal installments over four years, commencing on January 7, 2023.
F4 Restricted stock units granted on January 7, 2022 that vest in two equal installments over two years, commencing on January 7, 2023.
F5 This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.
F6 This option was granted on January 7, 2022 and vests in two equal installments over two years, commencing on January 7, 2023.